Tradestie Institutional Equity Comparison Engine
BDRX vs SLMT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDRX Overall Edge
BDRX Captures Institutional Edge (2โ0 Pillars ยท 2โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus SLMT at N/M Forward P/E and -4271.3% operating margin (+929.8% YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLMT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BDRX N/M vs SLMT N/M Fwd P/E
Growth & Margin Winner
BDRX
Op Margin 0.0% vs -4271.3% ยท YoY -64.1% vs +929.8%
Momentum & Technical Winner
BDRX
1Y -51.4% vs -61.3% ยท 52W Pos 18% vs 26%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX
NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap
$1.0M
1M Return
+352.9%
1Y Return
-51.42%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 50.0
SLMT
US Equity
SLMT
Institutional Equity
$2.24
-13.85% 1D
Market Cap
$28.6M
1M Return
-29.78%
1Y Return
-61.31%
Forward P/E
N/M
Unified AI Score
43.0 / 100
HOLD
Tech 33.0
Fund 50.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BDRX -51.42%
SLMT -61.31%
Spread: +9.89 pp (BDRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BDRX TTM Op. Margin: 0.0%
SLMT TTM Op. Margin: -4271.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs SLMT. Trailing 12-month operating profitability (BDRX 0.0% vs SLMT -4271.3%) and valuation multiples (BDRX N/M vs SLMT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BDRX | SLMT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.0M | $28.6M | Larger Scale | SLMT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -64.1% | +929.8% | Higher Growth | SLMT |
| Operating Margin (TTM) Profitability | 0.0% | -4271.3% | Higher Margin | BDRX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -42.0% | -795.8% | Higher ROE | BDRX |
| 52-Week Range Position Momentum | 18% ($0โ$9) | 26% ($1โ$7) | Stronger Trend | SLMT |
| Beta / 30D Volatility Risk Regime | 5.62ฮฒ ยท 2621% Vol | 7.98ฮฒ ยท 107% Vol | Lower Realized Risk | SLMT |
| Unified Institutional Score Composite Signal | 36.0 / 100 (SELL) | 43.0 / 100 (HOLD) | Higher Composite | SLMT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BDRX vs SLMT Buy Guide
BDRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SLMT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BDRX nor SLMT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.